Suppr超能文献

大鼠肝脏内吞去唾液酸胎球蛋白的命运

Fate of asialofetuin endocytosed by rat liver.

作者信息

Wattiaux R, Misquith S, Wattiaux-De Coninck S, Dubois F

机构信息

Laboratoire de Chimie Physiologique, Facultés Universitaires Notre-Dame de la Paix, Namur, Belgium.

出版信息

Biochem Biophys Res Commun. 1989 Jan 16;158(1):313-8. doi: 10.1016/s0006-291x(89)80214-1.

Abstract

We have investigated the endocytosis by rat liver of asialofetuin coupled to [125I] tyramine cellobiose: [125I] TCASF. Subcellular distribution of radioactive compounds was established after differential and isopycnic centrifugation and by analysing the fractions by SDS electrophoresis. Labelling secondary lysosomes was performed by injecting rats with Triton WR 1339 four days before injecting the protein. Results show that after being associated with endosomes [125I] TCASF is recovered in organelles where they are subjected to a first degradation, the density of these organelles is practically not affected by Triton WR 1339 injection. Later the degradation products are associated with lysosomes whose density is markedly lowered by Triton WR 1339 treatment. These observations suggest that the first intracellular organelles where [125I] TCASF is subjected to digestion are distinct from the secondary lysosome population. This could be in agreement with the hypothesis that supposes that endosomes acquire enzymes from primary lysosomes before fusion with secondary lysosomes.

摘要

我们研究了大鼠肝脏对与[125I]酪胺纤维二糖偶联的去唾液酸胎球蛋白([125I]TCASF)的内吞作用。通过差速离心和等密度离心,并通过SDS电泳分析各组分,确定了放射性化合物的亚细胞分布。在注射蛋白质前四天给大鼠注射曲拉通WR 1339,以标记次级溶酶体。结果表明,[125I]TCASF与内体结合后,在经历首次降解的细胞器中被回收,这些细胞器的密度实际上不受曲拉通WR 1339注射的影响。随后,降解产物与溶酶体结合,其密度因曲拉通WR 1339处理而显著降低。这些观察结果表明,[125I]TCASF进行消化的首个细胞内细胞器与次级溶酶体群体不同。这可能与以下假设一致,即假设内体在与次级溶酶体融合之前从初级溶酶体获得酶。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验